Research
-
AbbVie announces positive results from phase 3 study of Rinvoq in patients with rheumatoid arthritis
292 0AbbVie, a research-based global biopharmaceutical company, announced new long-term results…
Read more
AbbVie, a research-based global biopharmaceutical company, announced new long-term results…
Read more